Diabetes News and Research

Latest Diabetes News and Research

PhaseBio commences Glymera Phase 2b study in type 2 diabetes

PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.

22 Aug 2012

Eco-friendly blood glucose monitor developed by Cambridge Consultants

A blood glucose monitor concept for diabetics that’s simpler to use, less cumbersome to carry and has a third of the environmental impact of traditional devices has been developed by Cambridge Consultants.

21 Aug 2012

CKD may raise stroke, bleeding risk in AF patients

Danish study results show that the presence of chronic kidney disease appears to raise the risk for stroke, systemic thromboembolism, and bleeding among patients with atrial fibrillation.

21 Aug 2012

Healthy brown-bag lunch can combat obesity in school children

As the new school year approaches, parents have to decide what their children will eat for lunch. Should they help the kids brown bag it or remember to take their lunch money? While this might not seem to be a major issue, it is - because the importance of school lunch rises with the rates of childhood obesity, say University of Alabama at Birmingham experts.

21 Aug 2012

Berry wines may help people with diabetes decrease their blood sugar

In evaluating the bioactive compounds of Illinois blueberry and blackberry wines, University of Illinois scientists have found compounds that inhibit enzymes responsible for carbohydrate absorption and assimilation. And that could mean a tasty way to help people with diabetes decrease their blood sugar.

21 Aug 2012

New tools can help assess culturally competent and health-literate care

The latest additions to a set of surveys for evaluating patient experiences with medical care provide new tools for assessing culturally competent and health-literate care, according to a special September supplement to Medical Care.

21 Aug 2012

Methyl-glyoxal could play a major role in abdominal obesity, insulin resistance and type 2 diabetes

Researchers at Mount Sinai School of Medicine have identified a common compound in the modern diet that could play a major role in the development of abdominal obesity, insulin resistance, and type 2 diabetes.

21 Aug 2012

People with metabolic abnormalities may experience rapid decline in their cognitive skills

People who are obese and also have high blood pressure and other risk factors called metabolic abnormalities may experience a faster decline in their cognitive skills over time than others, according to a study published in the August 21, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology.

21 Aug 2012

Study finds decline in incidence of heart failure cases in Ontario

The number of new cases of heart failure in Ontario decreased 33% over a decade, suggesting preventive efforts may be working. However, mortality rates remain high for people with the disease, states a study published in CMAJ (Canadian Medical Association Journal).

21 Aug 2012

PD risk factors for potential clinical screening identified

A meta-analysis has identified 19 risk factors that significantly impact a person’s risk for Parkinson’s disease and could be of potential value for clinical screening, say the authors.

20 Aug 2012

Working out during pregnancy wards off muscle pain

Not enough healthy pregnant women are doing the recommended amount of physical exercise, suggest study findings.

20 Aug 2012

Enzalutamide extends castration-resistant prostate cancer survival

Enzalutamide treatment significantly improves survival in men with castration-resistant prostate cancer, demonstrate phase III trial results published in TheNew England Journal of Medicine.

20 Aug 2012

Hemodialysis foot ulcer risk not confined to diabetes

Hemodialysis patients with and without diabetes are at risk for foot ulceration, say UK researchers who believe preventive resources must be directed towards both patient groups.

20 Aug 2012

HPV genotype may alter chemoradiotherapy outcome

Human papillomavirus genotype predicts whether patients with cervical cancer will benefit from concurrent chemoradiation therapy, study findings suggest.

20 Aug 2012

Protein toxic to nerve cells in AD also contributes to memory loss

The underlying causes of Alzheimer's disease are not fully understood, but a good deal of evidence points to the accumulation of β-amyloid, a protein that's toxic to nerve cells. β-amyloid is formed by the activity of several enzymes, including one called BACE1. Most Alzheimer's disease patients have elevated levels of BACE1, which in turn leads to more brain-damaging β-amyloid protein.

20 Aug 2012

Abbott's XIENCE Xpedition Everolimus Eluting Coronary Stent System receives CE Mark in Europe

Abbott today announced that the XIENCE Xpedition Everolimus Eluting Coronary Stent System received CE Mark in Europe for the treatment of coronary artery disease.

20 Aug 2012

First Edition: August 20, 2012

Today's headlines focus on how the Medicare story is continuing to unfold on the presidential campaign trail.

20 Aug 2012

Vanderbilt University signs TIPQC to increase breast-feeding in hospitals and delivery centers

Vanderbilt University has signed on for a statewide project to increase exclusive breast-feeding in hospitals and delivery centers.

18 Aug 2012

Analysis shows inconsistency in research incentives for prisoners

When members of the public participate in research studies, they are often given incentives - such as cash or gift cards for food - as compensation or reimbursement for their time and effort. Not so for Canada's prison population. A new analysis shows that there is inconsistency in how and when incentives are used for research participants under criminal justice supervision.

18 Aug 2012

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

Teva Pharmaceutical Industries Ltd. announced today the launch of an authorized generic of ACTOplus met (pioglitazone/metformin tablets)15 mg/500 mg, 15 mg/850 mg.

18 Aug 2012

Diabetes News and Research

Latest Diabetes News and Research

PhaseBio commences Glymera Phase 2b study in type 2 diabetes

Eco-friendly blood glucose monitor developed by Cambridge Consultants

CKD may raise stroke, bleeding risk in AF patients

Healthy brown-bag lunch can combat obesity in school children

Berry wines may help people with diabetes decrease their blood sugar

New tools can help assess culturally competent and health-literate care

Methyl-glyoxal could play a major role in abdominal obesity, insulin resistance and type 2 diabetes

People with metabolic abnormalities may experience rapid decline in their cognitive skills

Study finds decline in incidence of heart failure cases in Ontario

PD risk factors for potential clinical screening identified

Working out during pregnancy wards off muscle pain

Enzalutamide extends castration-resistant prostate cancer survival

Hemodialysis foot ulcer risk not confined to diabetes

HPV genotype may alter chemoradiotherapy outcome

Protein toxic to nerve cells in AD also contributes to memory loss

Abbott's XIENCE Xpedition Everolimus Eluting Coronary Stent System receives CE Mark in Europe

First Edition: August 20, 2012

Vanderbilt University signs TIPQC to increase breast-feeding in hospitals and delivery centers

Analysis shows inconsistency in research incentives for prisoners

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

Genomics - Industry Focus eBook (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in